US HB4250 | 2013-2014 | 113th Congress
Status
Spectrum: Moderate Partisan Bill (Republican 27-8)
Status: Engrossed on July 29 2014 - 50% progression, died in chamber
Action: 2014-07-29 - Received in the Senate.
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on July 29 2014 - 50% progression, died in chamber
Action: 2014-07-29 - Received in the Senate.
Text: Latest bill text (Engrossed) [PDF]
Summary
Sunscreen Innovation Act - (Sec. 2) Amends the Federal Food, Drug, and Cosmetic Act to establish a process for the review and approval of over-the-counter (OTC) sunscreen active ingredients. Allows any person to request that the Secretary of Health and Human Services (HHS) determine whether an OTC sunscreen active ingredient or combination of ingredients is safe and effective. Requires the Secretary to review any request regarding a sunscreen active ingredient or combination of ingredients that has been in use and that is not included in the stayed sunscreen monograph published by the Food and Drug Administration (FDA). Directs the Secretary to invite the sponsor of the request to provide data and other information on the safety and efficacy of the sunscreen active ingredient or combination of ingredients. Requires the Secretary to determine whether the provided information is sufficient to conduct a review, and if so, file the request, and if not, explain to the sponsor why the provided information is insufficient. Requires the Director of the Center for Drug Evaluation and Research to complete a review of a filed request and determine the safety and efficacy of the sunscreen active ingredient or combination of ingredients within 300 days for new requests or a shorter timeframe for requests pending before enactment of this Act. Directs the Commissioner of Food and Drugs to make the determination if the Director does not make a determination in the allowed timeframe. Allows sunscreen active ingredients that are determined to be safe and effective to be used in OTC sunscreen products. Directs the Comptroller General (GAO) to report on the progress of the Secretary in establishing this process and the role of the Commissioner of Food and Drugs in issuing determinations on pending requests. Requires the Secretary to report on the decisions made about the safety and efficacy of sunscreen active ingredients, the amount of time between submission and decision for each request, the cost of the review process, and recommended improvements to the review process.
Title
Sunscreen Innovation Act
Sponsors
Rep. Ed Whitfield [R-KY] | Rep. Garland Barr [R-KY] | Rep. John Barrow [D-GA] | Rep. Timothy Bishop [D-NY] |
Sen. Marsha Blackburn [R-TN] | Rep. John Carney [D-DE] | Rep. Steve Chabot [R-OH] | Rep. Ander Crenshaw [R-FL] |
Rep. Charles Dent [R-PA] | Rep. Mario Diaz-Balart [R-FL] | Rep. John Dingell [D-MI] | Rep. Renee Ellmers [R-NC] |
Rep. Sam Farr [D-CA] | Rep. Charles Fleischmann [R-TN] | Rep. Randy Forbes [R-VA] | Rep. Tom Graves [R-GA] |
Rep. Tim Griffin [R-AR] | Rep. Brett Guthrie [R-KY] | Rep. Bill Johnson [R-OH] | Rep. Jack Kingston [R-GA] |
Rep. Leonard Lance [R-NJ] | Sen. James Lankford [R-OK] | Rep. Robert Latta [R-OH] | Rep. Carolyn Maloney [D-NY] |
Rep. Jim Matheson [D-UT] | Rep. Tim Murphy [R-PA] | Rep. Kristi Noem [R-SD] | Rep. Ed Perlmutter [D-CO] |
Rep. James Renacci [R-OH] | Rep. Harold Rogers [R-KY] | Rep. Thomas Rooney [R-FL] | Rep. Peter Roskam [R-IL] |
Rep. Dennis Ross [R-FL] | Rep. Steve Stivers [R-OH] | Rep. Patrick Tiberi [R-OH] |
History
Date | Chamber | Action |
---|---|---|
2014-07-29 | Senate | Received in the Senate. |
2014-07-28 | House | Motion to reconsider laid on the table Agreed to without objection. |
2014-07-28 | House | On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6928-6930) |
2014-07-28 | House | DEBATE - The House proceeded with forty minutes of debate on H.R. 4250. |
2014-07-28 | House | Considered under suspension of the rules. (consideration: CR H6928-6933) |
2014-07-28 | House | Mr. Whitfield moved to suspend the rules and pass the bill, as amended. |
2014-07-24 | House | Placed on the Union Calendar, Calendar No. 418. |
2014-07-24 | House | Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-558. |
2014-07-15 | House | Ordered to be Reported (Amended) by Voice Vote. |
2014-07-15 | House | Committee Consideration and Mark-up Session Held. |
2014-07-14 | House | Committee Consideration and Mark-up Session Held. |
2014-06-19 | House | Forwarded by Subcommittee to Full Committee (Amended) by Unanimous Consent . |
2014-06-19 | House | Subcommittee Consideration and Mark-up Session Held. |
2014-03-14 | House | Referred to the Subcommittee on Health. |
2014-03-13 | House | Referred to the House Committee on Energy and Commerce. |
Same As/Similar To
SB2141 (Same As) 2014-11-26 - Became Public Law No: 113-195.
Subjects
Congressional oversight
Consumer affairs
Drug safety, medical device, and laboratory regulation
Health
Health promotion and preventive care
Musculoskeletal and skin diseases
Consumer affairs
Drug safety, medical device, and laboratory regulation
Health
Health promotion and preventive care
Musculoskeletal and skin diseases